Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase - PubMed (original) (raw)
. 2004 Jan 15;13(2):159-70.
doi: 10.1093/hmg/ddh019. Epub 2003 Nov 25.
Daniel J Fadale, Jeffrey Anderson, Guilian M Xu, Victoria Gonzales, Nancy A Jenkins, Neal G Copeland, Michael K Lee, Linda H Younkin, Steven L Wagner, Steven G Younkin, David R Borchelt
Affiliations
- PMID: 14645205
- DOI: 10.1093/hmg/ddh019
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase
Joanna L Jankowsky et al. Hum Mol Genet. 2004.
Abstract
Amyloid precursor protein (APP) is endoproteolytically processed by BACE1 and gamma-secretase to release amyloid peptides (Abeta40 and 42) that aggregate to form senile plaques in the brains of patients with Alzheimer's disease (AD). The C-terminus of Abeta40/42 is generated by gamma-secretase, whose activity is dependent upon presenilin (PS 1 or 2). Missense mutations in PS1 (and PS2) occur in patients with early-onset familial AD (FAD), and previous studies in transgenic mice and cultured cell models demonstrated that FAD-PS1 variants shift the ratio of Abeta40 : 42 to favor Abeta42. One hypothesis to explain this outcome is that mutant PS alters the specificity of gamma-secretase to favor production of Abeta42 at the expense of Abeta40. To test this hypothesis in vivo, we studied Abeta40 and 42 levels in a series of transgenic mice that co-express the Swedish mutation of APP (APPswe) with two FAD-PS1 variants that differentially accelerate amyloid pathology in the brain. We demonstrate a direct correlation between the concentration of Abeta42 and the rate of amyloid deposition. We further show that the shift in Abeta42 : 40 ratios associated with the expression of FAD-PS1 variants is due to a specific elevation in the steady-state levels of Abeta42, while maintaining a constant level of Abeta40. These data suggest that PS1 variants do not simply alter the preferred cleavage site for gamma-secretase, but rather that they have more complex effects on the regulation of gamma-secretase and its access to substrates.
Similar articles
- Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.
Mastrangelo P, Mathews PM, Chishti MA, Schmidt SD, Gu Y, Yang J, Mazzella MJ, Coomaraswamy J, Horne P, Strome B, Pelly H, Levesque G, Ebeling C, Jiang Y, Nixon RA, Rozmahel R, Fraser PE, St George-Hyslop P, Carlson GA, Westaway D. Mastrangelo P, et al. Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8972-7. doi: 10.1073/pnas.0500940102. Epub 2005 Jun 10. Proc Natl Acad Sci U S A. 2005. PMID: 15951428 Free PMC article. - Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H, Capell A, Leimer U, Haass C. Steiner H, et al. Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653281 Review. - Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.
Czirr E, Leuchtenberger S, Dorner-Ciossek C, Schneider A, Jucker M, Koo EH, Pietrzik CU, Baumann K, Weggen S. Czirr E, et al. J Biol Chem. 2007 Aug 24;282(34):24504-13. doi: 10.1074/jbc.M700618200. Epub 2007 Jun 15. J Biol Chem. 2007. PMID: 17573346 - Characterization of the reconstituted gamma-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin [correction of nacastrin], aph-1a, and pen-2.
Zhang L, Lee J, Song L, Sun X, Shen J, Terracina G, Parker EM. Zhang L, et al. Biochemistry. 2005 Mar 22;44(11):4450-7. doi: 10.1021/bi0481500. Biochemistry. 2005. PMID: 15766275 - BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R. Vassar R. J Mol Neurosci. 2004;23(1-2):105-14. doi: 10.1385/JMN:23:1-2:105. J Mol Neurosci. 2004. PMID: 15126696 Review.
Cited by
- Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
Arezoumandan S, Cai X, Kalkarni P, Davis SA, Wilson K, Ferris CF, Cairns NJ, Gitcho MA. Arezoumandan S, et al. Neurosci Lett. 2021 Jul 27;758:136010. doi: 10.1016/j.neulet.2021.136010. Epub 2021 Jun 9. Neurosci Lett. 2021. PMID: 34090937 Free PMC article. - Peroxiredoxin 6 mediates protective function of astrocytes in Aβ proteostasis.
Pankiewicz JE, Diaz JR, Martá-Ariza M, Lizińczyk AM, Franco LA, Sadowski MJ. Pankiewicz JE, et al. Mol Neurodegener. 2020 Sep 9;15(1):50. doi: 10.1186/s13024-020-00401-8. Mol Neurodegener. 2020. PMID: 32907613 Free PMC article. - All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer's disease.
St-Pierre MK, VanderZwaag J, Loewen S, Tremblay MÈ. St-Pierre MK, et al. Front Cell Neurosci. 2022 Aug 12;16:932572. doi: 10.3389/fncel.2022.932572. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36035256 Free PMC article. Review. - Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells.
Pihlaja R, Takkinen J, Eskola O, Vasara J, López-Picón FR, Haaparanta-Solin M, Rinne JO. Pihlaja R, et al. J Neuroinflammation. 2015 Apr 28;12:81. doi: 10.1186/s12974-015-0305-9. J Neuroinflammation. 2015. PMID: 25927213 Free PMC article. - Anesthesia and tau pathology.
Whittington RA, Bretteville A, Dickler MF, Planel E. Whittington RA, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:147-55. doi: 10.1016/j.pnpbp.2013.03.004. Epub 2013 Mar 25. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23535147 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases